Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bittium Oyj Director's Dealing 2020

Mar 23, 2020

3258_rns_2020-03-23_45117bd5-90a6-41fc-b294-a009f94fc25d.html

Director's Dealing

Open in viewer

Opens in your device viewer

Bittium Corporation: Notification of Manager’s Transactions

Bittium Corporation: Notification of Manager’s Transactions

Stock Exchange Release

Free for publication on March 23, 2020 at 11.30 a.m. (CET+1)

Bittium Corporation: Notification of Manager’s Transactions

Person subject to the notification requirement

Name: Hannu Huttunen
Position: CEO

Notification type: Initial Notification
Reference number:  743700NFG5W5I59OVX65_20200320102104_4

Issuer: Bittium Corporation
LEI: 743700NFG5W5I59OVX65

Transaction date: March 19, 2020
Venue: XHEL
Instrument: Share
ISIN: FI0009007264
Nature of transaction: Acquisition

Transaction details

  1. Volume: 942, unit price: 3.61500 EUR
  2. Volume: 58, unit price: 3.61500 EUR
  3. Volume: 659, unit price: 3.61000 EUR
  4. Volume: 341, unit price: 3.61000 EUR

Aggregated transactions

Volume: 2,000
Volume weighted average price: 3.61250 EUR

Oulu, March 23, 2020
Hannu Huttunen
CEO

Further information:

Kari Jokela
Chief Legal Officer
Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and
connectivity solutions leveraging its 30 year legacy of expertise in advanced
radio communication technologies. Bittium provides innovative products and
services, customized solutions based on its product platforms and R&D services.
Complementing its communications and connectivity solutions, Bittium offers
proven information security solutions for mobile devices and portable computers.
Bittium also provides healthcare technology products and services for biosignal
measuring in the areas of cardiology, neurology, rehabilitation, occupational
health and sports medicine. Net sales in 2019 were EUR 75.2 million and
operating profit was EUR 6.3 million. Bittium is listed on Nasdaq Helsinki.
www.bittium.com

Attachments: